This trial looks at how well MRI works in finding and staging prostate cancer, which may help treatment planning.
- Prostate Cancer
2 Primary · 1 Secondary · Reporting Duration: Up to 2 years
1 Treatment Group
1 of 1
852 Total Participants · 1 Treatment Group
Primary Treatment: Multiparametric Magnetic Resonance Imaging · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · Male Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment currently available for this clinical experiment?
"Per the data available on clinicaltrials.gov, enrollment is ongoing for this medical trial that was initially posted in July of 2018 and last updated at the end of June 2022." - Anonymous Online Contributor
How many research participants are currently included in this experiment?
"To complete this trial, 852 participants that meet the enumerated criteria need to be recruited. There are two primary sites offering participation in this study: Mayo Clinic Hospital located in Phoenix, Arizona and another location at the original Mayo Clinic facility in Rochester, Minnesota." - Anonymous Online Contributor
Is there a substantial presence of this research taking place in North America?
"This trial has 43 active sites, such as Mayo Clinic Hospital in Phoenix, Mayo Clinic Rochester and Mayo Clinic Arizona Scottsdale." - Anonymous Online Contributor